Assessment of variables associated with prolonged admission duration in children with Mycoplasma pneumoniae pneumonia

Clin Respir J. 2022 Nov;16(11):756-767. doi: 10.1111/crj.13549. Epub 2022 Oct 7.

Abstract

Introduction: Macrolide-resistant Mycoplasma pneumoniae (MRMP) has become prevalent in children. This study investigated the clinical and laboratory variables of MRMP and macrolide-sensitive M. pneumoniae (MSMP) and identified factors associated with prolonged hospital admission in children.

Methods: A prospective multicenter study was conducted in 1063 children <18 years old in July 2018-June 2020. The 454 had a positive M. pneumoniae polymerase chain reaction assay.

Results: Most subjects had MRMP (78.4%), and all mutated strains had the A2063G transition. We defined MRMP* (n = 285) as MRMP pneumonia requiring admission and MSMP* (n = 72) as MSMP pneumonia requiring admission. Patients with MRMP pneumonia were older, more likely to have segmental/lobar pneumonia, and had more febrile days than those with MSMP pneumonia. C-reactive protein (CRP), lactate dehydrogenase (LDH), and percentage neutrophils were more strongly associated with MRMP* than MSMP* groups. Percentage neutrophils, CRP, and alanine aminotransferase significantly changed between admission and follow-up measurements in patients with MRMP* (P < 0.05). The duration of admission positively correlated with the number of febrile days after initiation of antibiotic medication and laboratory variables (white blood cell count, CRP, and aspartate aminotransferase [AST]) (P < 0.05). Random forest analysis indicated that the number of febrile days after initiation of antibiotic medication, AST, and percentage neutrophils at admission was over five.

Conclusions: This study indicated that children with M. pneumoniae pneumonia with a higher number of febrile days after initiation of antibiotic medication, AST, and percentage neutrophils at admission were more likely to have prolonged admission duration.

Keywords: M. pneumoniae; aspartate aminotransferase; children; macrolide-resistant M. pneumoniae; neutrophil portion.

Publication types

  • Multicenter Study

MeSH terms

  • Adolescent
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • C-Reactive Protein
  • Child
  • Drug Resistance, Bacterial
  • Humans
  • Macrolides / pharmacology
  • Macrolides / therapeutic use
  • Mycoplasma pneumoniae* / genetics
  • Pneumonia, Mycoplasma* / drug therapy
  • Pneumonia, Mycoplasma* / epidemiology
  • Prospective Studies

Substances

  • Macrolides
  • Anti-Bacterial Agents
  • C-Reactive Protein